Home › Core › ISCC-IDs › 28CrZLsvH4Zg3

View ISCC-ID

Core Data

28CrZLsvH4Zg3
ISCC-ID - digital asset identifier
CCL1TVeVM2dqf-CThicF84eJh8T-CDX4paPRtyZp4-CRX4WSwbKJ21j
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

safety and effectiveness of interferon β1a intramuscular therapy results of the postmarketing drug surveillance in japan

Ledger Reference

coblo
Source Ledger/Blockchain
308891
N-th ISCC Decleration on source ledger
7b9be22777d2b374df3ffc3e8dfe9cf7db910154138342e02f67698e4123f4dd
Hash of block that includes the ISCC-DECLARATION
d1316b5bd367da634ac962697ad1e4af7741a6825ec1aed8e7cad349e0c54900
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Safety and effectiveness of interferon \u03b2-1a intramuscular therapy: results of the postmarketing drug surveillance in Japan", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Haruki Makioka", "@type": "Person"}, {"name": "Fuyuki Nakaya", "@type": "Person"}, {"name": "Yan Ling", "@type": "Person"}, {"name": "Shinichi Torii", "@type": "Person"}, {"name": "Takahiko Saida", "@type": "Person"}, {"name": "Jun-ichi Kira", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.jstage.jst.go.jp/article/clinicalneurol/57/10/57_cn-001074/_pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Societas Neurologica Japonica", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.5692/clinicalneurol.cn-001074", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCL1TVeVM2dqf-CThicF84eJh8T-CDX4paPRtyZp4-CRX4WSwbKJ21j", "propertyID": "ISCC"}], "datePublished": "2017-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close